Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


All chapters
Previous chapter Next chapter

Chapter 13

Toxicology and Anticancer Activity of Synthetic Organoselenium Compounds

This chapter describes briefly the toxicity of selenium compounds with a special emphasis on synthetic organoselenium compounds. Since the discovery of selenium in the 19th century, several studies have been published about the paradoxical health and toxic effects of selenium. The essentiality of selenium to life is directly related to its incorporation into a small number of proteins, selenoproteins, most of them with antioxidant activity. Conversely, the toxicity of selenium is related to the pro-oxidant activity of selenium metabolites and the consequent generation of reactive species. Selenium compounds, based on their anti- and pro-oxidant activity have been used as potential chemopreventive and chemotherapeutic agents. The use of selenium in cancer treatment is summarized. Futhermore, synthetic organoselenium compounds, for instance, ebselen, diselenides, selenocyanates and 3′-azido-3′-deoxythymidine (AZT) derivatives, are presented as potential anticancer agents. Finally, the main target molecules forcancer therapy related to the organoselenium compounds are presented, based in an in silico vision.

Publication details


Print publication date
03 Oct 2017
Copyright year
2018
Print ISBN
978-1-78801-029-0
PDF eISBN
978-1-78801-190-7
ePub eISBN
978-1-78801-223-2